
$2.42K
1
1

1 market tracked

No data available
| Market | Platform | Price |
|---|---|---|
![]() | Poly | 9% |
Trader mode: Actionable analysis for identifying opportunities and edge
This market will resolve to "Yes" if the World Health Organization (WHO) declares a new COVID pandemic other than COVID-19 (SARS-CoV-2) between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source will be official announcements from the World Health Organization.
Prediction markets currently assign a low probability to the declaration of a new coronavirus pandemic by the end of 2026. On Polymarket, the "Yes" share trades at approximately 10 cents, implying the market sees only a 10% chance of this event occurring. This price suggests the consensus view is that a new WHO-declared pandemic from a novel coronavirus is unlikely within this timeframe, though not impossible. The market has thin liquidity, with only about $2,000 in total volume, indicating limited trader confidence and higher potential price volatility.
Two primary factors are suppressing the market's probability estimate. First, the historical baseline for novel coronavirus emergence leading to a global pandemic is statistically low. While coronaviruses spill over from animal reservoirs periodically, the jump to sustained human-to-human transmission causing a worldwide pandemic is a rare event. The SARS outbreak in 2003 and the COVID-19 pandemic are notable exceptions over decades. Second, the global public health infrastructure remains on high alert and is arguably more prepared for early detection and containment than in 2019. Enhanced surveillance, vaccine platform technologies, and international reporting frameworks could, in theory, mitigate a novel virus before it reaches pandemic status.
The odds could shift significantly with a major outbreak of a novel coronavirus exhibiting high transmissibility and severity. Key monitoring points include any WHO "Disease Outbreak News" alerts concerning a novel coronavirus or declarations of a Public Health Emergency of International Concern (PHEIC). A sustained, uncontrolled outbreak in a region with dense international travel links would be a primary catalyst for traders to reprice this market upward. Conversely, the odds may drift lower if the world passes symbolic dates, like the end of 2024, without a major new coronavirus threat materializing. The thin liquidity means any credible news headline could cause a sharp, disproportionate price movement.
AI-generated analysis based on market data. Not financial advice.
$2.42K
1
1
This prediction market addresses whether the World Health Organization will declare a new coronavirus pandemic distinct from COVID-19 before the end of 2026. A pandemic declaration by the WHO is a formal recognition that a new infectious disease has spread across multiple countries or continents, affecting a significant number of people. The resolution depends on an official WHO announcement specifically identifying a novel coronavirus, not a variant of SARS-CoV-2, as the cause of a new pandemic. This topic sits at the intersection of virology, global public health policy, and pandemic preparedness, reflecting ongoing scientific concern about zoonotic spillover events and viral evolution. Interest stems from the profound global impact of the COVID-19 pandemic, which began in 2019, and the recognition that coronaviruses represent a significant pandemic threat. Recent scientific reports, including from the WHO's own advisory bodies, continue to highlight coronaviruses as priority pathogens for research and surveillance. The market allows participants to weigh evidence from viral surveillance, genomic sequencing, and epidemiological reports against the historical frequency of novel coronavirus emergence.
The history of coronavirus outbreaks provides critical context for assessing the likelihood of a new pandemic. Before 2002, coronaviruses were primarily known to cause mild common colds in humans. This changed with the 2002-2004 SARS-CoV-1 outbreak, which originated in China and spread to 29 countries, causing over 8,000 cases and 774 deaths with a case fatality rate near 10%. The Middle East Respiratory Syndrome (MERS) coronavirus emerged in Saudi Arabia in 2012 and continues to cause sporadic zoonotic outbreaks, with a case fatality rate of approximately 35%. The most significant event was the emergence of SARS-CoV-2, the virus causing COVID-19. The WHO declared COVID-19 a PHEIC on January 30, 2020, and began describing it as a pandemic in March 2020. This pandemic has resulted in over 700 million confirmed cases and nearly 7 million reported deaths globally as of late 2024. These three major outbreaks in less than two decades demonstrate the coronavirus family's pandemic potential. Scientific consensus indicates that the diversity of coronaviruses in animal reservoirs, particularly bats, and increasing human-animal interface create ongoing spillover risk. The interval between the emergence of SARS-CoV-1 and SARS-CoV-2 was about 17 years.
The declaration of a new coronavirus pandemic would trigger immediate and profound global consequences. Economically, it would likely disrupt supply chains, travel, and commerce on a scale similar to the initial COVID-19 shock, potentially costing trillions of dollars in lost output and stimulus spending. Financially, it would create extreme volatility in markets and test the debt sustainability of nations still recovering from the previous pandemic. Politically, it would be a severe test of international cooperation, the revised International Health Regulations, and proposed pandemic treaties. National responses would vary, potentially leading to border closures, trade restrictions, and geopolitical friction, especially if the origin of the virus becomes contested. Socially and in terms of public health, a new pandemic would strain healthcare systems, reignite debates over non-pharmaceutical interventions like masking and distancing, and challenge vaccine equity frameworks. It would have a direct impact on virtually every person on Earth through health risks, behavioral restrictions, and economic hardship. The psychological impact of a second major pandemic in a decade could be severe, affecting public trust in institutions and science.
As of late 2024, no novel coronavirus causing sustained human-to-human transmission has been identified since SARS-CoV-2. Global surveillance for respiratory pathogens remains heightened post-COVID-19. The WHO and partners continue to monitor known coronaviruses like MERS, which causes sporadic cases, primarily in the Arabian Peninsula. Scientific research into coronavirus diversity, particularly through projects like USAID's PREDICT and DEEP VZN, continues to identify novel viruses in animal populations, assessing their spillover risk. The WHO is actively negotiating a new pandemic agreement and amendments to the International Health Regulations (2005), aiming to strengthen the global system for preventing and responding to pandemics, with a focus on equity and timely data sharing. These reforms, however, are not yet finalized or implemented.
An epidemic refers to a disease outbreak that affects a large number of people within a specific community, population, or region. A pandemic is an epidemic that has spread over multiple countries or continents, usually affecting a substantial global population. The WHO typically uses the term pandemic to describe worldwide spread of a new disease for which most people do not have immunity.
The WHO does not have a single formal mechanism for 'declaring a pandemic.' The key official declaration is a Public Health Emergency of International Concern (PHEIC). If a disease, such as a novel coronavirus, meets the criteria for a PHEIC under the International Health Regulations and demonstrates sustained worldwide spread, the WHO Director-General and officials will begin describing the situation as a pandemic based on technical assessments from advisory groups.
Bats are considered the primary natural reservoir for many coronaviruses with human pandemic potential, including the progenitors of SARS-CoV-1, MERS-CoV, and SARS-CoV-2. Other intermediate hosts have included palm civets (SARS) and dromedary camels (MERS). Coronaviruses are also widespread in other mammals and birds, making surveillance complex.
The origin of any new pathogen would be investigated. The two main hypotheses for novel coronavirus emergence are zoonotic spillover (natural transmission from animals) and laboratory incident. The WHO states that the SARS-CoV-2 virus most likely has a zoonotic origin, but all potential pathways must be considered for future threats, highlighting the importance of robust biosafety standards in virology research.
Global preparedness is mixed. Positively, scientific understanding, vaccine platform technology, and surveillance are more advanced. mRNA vaccine technology proved effective against COVID-19. However, political will for sustained funding, international data-sharing agreements, and equitable distribution of medical countermeasures remain significant challenges, as evidenced by the 'vaccine apartheid' during COVID-19.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.
Share your predictions and analysis with other traders. Coming soon!

No related news found
Add this market to your website
<iframe src="https://predictpedia.com/embed/pKpbrh" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="New Coronavirus Pandemic in 2026?"></iframe>